| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |